By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MolecularHealth today said that it has signed a five-year deal with the US Food and Drug Administration to evaluate and refine the firm's software system for mechanism-based drug safety assessment and prediction.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.